Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-23-020422
Filing Date
2023-11-09
Accepted
2023-11-09 16:10:11
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm   iXBRL 10-Q 973958
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 5374
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 4838
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3034
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 3168
  Complete submission text file 0001062993-23-020422.txt   5700346

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igxt-20230930.xsd EX-101.SCH 81227
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igxt-20230930_cal.xml EX-101.CAL 36347
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igxt-20230930_def.xml EX-101.DEF 150717
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igxt-20230930_lab.xml EX-101.LAB 903646
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igxt-20230930_pre.xml EX-101.PRE 281578
66 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 675074
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

EIN.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31187 | Film No.: 231392456
SIC: 2834 Pharmaceutical Preparations